State of the nephrological service: renal replacement therapy in the Russian Federation from 2015 to 2019


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Background. Chronic kidney disease (CKD) is a serious medical and socio-economic problem in the Russian federation (RF). Competent primary and secondary prevention of ckd along with adequate provision of renal replacement therapy (RRT) to the population are the key to reducing mortality, frequency of complications, disease progression rate and the treatment cost. Problem. Over the past ten years, the provision of RRT to the population of the Russian federation has increased, but at the moment it still does not correspond to the real need for it, which is associated with both insufficient rates of rrt development and low detection of ckd patients. lack of secondary prevention, qualified personnel shortage and untimely primary diagnostics lead to a high prevalence of end-stage ckd and an increase in treatment costs. objective. this article reflects the trends in rrt development in the Russian federation for the period 2015-2019 according to the Report of the Russian Dialysis Society and the Reports of the Russian transplant Society, as well as new data from the specialized commission of the expert council on nephrology of the ministry of health of the Russian federation. Conclusion. The RRT system in the Russian federation has been continuously developing since 1998, however, there are still serious differences in the availability of rrt between the regions of the country. a number of parameters of medical care for patients with end-stage ckd still require close attention: the availability of rrt and simultaneously improved screening systems for ckd in risk groups, clarification of the government statistics system, improving the quality of drug provision for patients with end-stage ckd and the development of the transplantation system.

Full Text

Restricted Access

About the authors

E. M Shilov

Sechenov First Moscow State Medical University (Sechenov University)

Moscow, Russia

O. N Kotenko

Peoples’ Friendship University of Russia

Moscow, Russia

M. M Shilova

Pirogov Russian National Research Medical University

Moscow, Russia

K. S Milchakov

Sechenov First Moscow State Medical University (Sechenov University), Higher School of Healthcare Management, Institute of Leadership and Healthcare Management

Moscow, Russia

M. A Gabaev

Sechenov First Moscow State Medical University (Sechenov University), Higher School of Healthcare Management, Institute of Leadership and Healthcare Management

Moscow, Russia

R. A Khalfin

Sechenov First Moscow State Medical University (Sechenov University), Higher School of Healthcare Management, Institute of Leadership and Healthcare Management

Moscow, Russia

References

  1. Milchakov K., Shilov E., Shvetzov M.Y., Fomin V., Khalfin R, Madyanova V, и др. Management of chronic kidney disease in the Russian Federation: A critical review of prevalence and preventive programmes. Int. J Healthc Manag. 2018;1-5.
  2. Bikbov B.T., Tomilina N.A. Renal replacement therapy for ESRD in Russian Federation, 1998-2013. Nephrol Dyalisis. 2015;17(3):160.
  3. Tomilina N.A., Andrusev A.M., Peregudova N.G., Shinkareva M.B. Russian National Renal Replacement Therapy Registry Report of Russian Public Organization of Nephrologists «Russian Dialysis Society». Nephrol Dial. 2018;19 (4 Supplement).
  4. Андрусев А.М., Перегудова Н.Г., Шинкарева М.Б., Томилина Н.А. Заместительная терапия терминальной хронической почечной недостаточности в российской федерации 2014-2018 гг. [Интернет]. О.О.О.Н. «Российское Диализное Общество»; 2019. Доступно на: http://nephro.ru/ content/fles/registr/Registr_2014-2018_short.PDF
  5. ERA-EDTA Registry. ERA-EDTA Registry Annual Report 2015. Academic Medical Center, Department of Medical Informatics, Amsterdam, the Netherlands. 2017.
  6. Grassmann A., Gioberge S., Moeller S., Al. E. ESRD patients in 2004: global overview of patient numbers, treatment modalities and associated trends. Nephrol Dial Transpl. 2005;20:2587-93.
  7. Saran R., Robinson B., Abbott K.C., Agodoa L.Y.C., Albertus P., Ayanian J. US Renal Data System 2016 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am J Kidney Dis. 2017;69(3):A7-8.
  8. Gautier S.V., Moysyuk Y.G., Khomyakov S.M. Organ donation and transplantation in russian federation in 2012 (V report of National Registry). Russ J Transplantology Artif Organs. 2014;15(2):8.
  9. Gautier S.V., Moysyuk Y.G., Khomyakov S.M. Organ donation and transplantation in the russian federation in 2013 6th report of National Register. Russ J Transplantology Artif Organs. 2014;16(2):5-23.
  10. Gautier S.V., Moysyuk YaG., Khomyakov S.M. Organ donation and transplantation in the russian federation in 2014 7th report of national register. Russ J Transplantology Artif Organs. 2015;17(2):7-22.
  11. Gautier S.V., Khomyakov S.M. Organ donation and transplantation in russian federation in 2015. 8th report of National Register. Russ J Transplantology Artif Organs. 2016;18(2):6-26.
  12. Lopez A.D., Mathers C.D., Ezzati M., Jamison D.T., Murray C.J. Global Burden of Disease and Risk Factors [Интернет]. The International Bank for Reconstruction and Development / The World Bank; 2006. Доступно на: http://www.ncbi.nlm.nih.gov/pubmed/21250374
  13. Benghanem GharbiM., ElseviersM., ZamdM., BelghitiAlaouiA., BenahadiN., Trabelssi E.H. Chronic kidney disease, hypertension, diabetes, and obesity in the adult population of Morocco: how to avoid “over”- and “under”-diagnosis of CKD. Kidney Int. 2016;89(6):1363-1371.
  14. Crews D.C., Plantinga L.C., Miller E.R., Saran R., Hedgeman E., Saydah S.H. et al. Prevalence of Chronic Kidney Disease in Persons With Undiagnosed or Prehypertension in the United States. Hypertension. 2010;55(5):1102-1109.
  15. Levin A., Tonelli M., Bonventre J., Coresh J., Donner J.-A., Fogo A.B. et al. Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy. The Lancet [Интернет]. 2017 г.; Доступно на: http:// linkinghub.elsevier.com/retrieve/pii/S0140673617307882
  16. Grams M.E., Juraschek S.P., Selvin E., Foster M.C., Inker L.A., Eckfeldt J.H., et al. Trends in the Prevalence of Reduced GFR in the United States: A Comparison of Creatinine- and Cystatin C-Based Estimates. Am J Kidney Dis. 2013;62(2):253-260.
  17. HillN.R., Fatoba S.T., Oke J.L., Hirst J.A., O’Callaghan C.A., Lasserson D.S., et al. Global prevalence of chronic kidney disease - A systematic review and meta-analysis. 2016.
  18. Sherwood M., McCullough P.A. Chronic kidney disease from screening, detection, and awareness, to prevention. Lancet Glob Health. 2016;4(5):e288-e289.

Supplementary files

Supplementary Files
Action
1. JATS XML

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies